NORTHERN TRUST CORP - QUALIGEN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$12,000
-52.0%
43,2530.0%0.00%
Q2 2022$25,000
-13.8%
43,2530.0%0.00%
Q1 2022$29,000
-37.0%
43,2530.0%0.00%
Q4 2021$46,000
-17.9%
43,2530.0%0.00%
Q3 2021$56,000
-34.9%
43,2530.0%0.00%
Q2 2021$86,000
-26.5%
43,2530.0%0.00%
Q1 2021$117,0000.0%43,253
+11.7%
0.00%
Q4 2020$117,00038,7310.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 80,094$104,0000.08%
PERKINS CAPITAL MANAGEMENT INC 51,178$67,0000.04%
HATTON CONSULTING, INC. 27,195$35,0000.03%
GSA CAPITAL PARTNERS LLP 78,687$102,0000.01%
CRA Financial Services, LLC 19,957$26,0000.01%
Virtu Financial LLC 25,507$33,0000.00%
WEDBUSH SECURITIES INC 32,228$42,0000.00%
TWO SIGMA SECURITIES, LLC 15,347$20,0000.00%
UBS Group AG 13,118$17,0000.00%
US BANCORP \DE\ 9,047$12,0000.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders